Rocket Lab shares rose 4.65% to $75.69 on February 09, 2026. Intraday trading saw the stock climb as much as 5.01% to reach $75.94. This recovery follows a period of selling pressure after Congress declined funding for the planned 2031 Mars sample-return mission.
The stock previously fell 9.7% on February 07 following a Neutron tank rupture. Investors are currently weighing these recent setbacks against prior momentum gained from a Space Force contract. Technical indicators remain mixed following the recent volatility.
The upward movement aligns with a broader market trend as the NASDAQ gained 1.16%. No new company-specific catalysts were reported to drive the Monday price action.